DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing
of Modified DNA On-Demand
PARIS and SOUTH SAN FRANCISCO, Calif., February 23, 2021 DNA Script, SAS, a leading pioneer in enabling DNA synthesis on demand, and baseclick GmbH announced today an exclusive licensing agreement that grants DNA Script use of the novel Click chemistry commercialized by baseclick. In effect, this agreement enables DNA Script s customers to enzymatically synthesize high purity nucleic acids with modifications using their SYNTAX™ DNA printing system.
Click chemistry was originally developed by scientists at The Scripps Research Institute
1 as a simple and easy way to chemically add modifications, like dyes, onto biomolecules. baseclick expanded the utilization of Click technology by linking moieties onto nucleic acids. The terms of the agreement allow for DNA Script to sell reagent kits with baseclick s technology